×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TMDX – transmedics group, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TMDX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/28
01:00 pm
tmdx
Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]
Medium
Report
Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]
2/27
07:26 am
tmdx
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]
Medium
Report
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]
2/27
07:00 am
tmdx
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
Medium
Report
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
2/26
12:35 pm
tmdx
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]
2/25
01:03 pm
tmdx
TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
12:58 pm
tmdx
TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
Low
Report
TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
2/25
12:58 pm
tmdx
TransMedics Group (TMDX) had its price target raised by JPMorgan Chase & Co. from $114.00 to $149.00. They now have a "neutral" rating on the stock.
Low
Report
TransMedics Group (TMDX) had its price target raised by JPMorgan Chase & Co. from $114.00 to $149.00. They now have a "neutral" rating on the stock.
2/25
10:24 am
tmdx
TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
Medium
Report
TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/4
09:41 pm
tmdx
Form 4 TransMedics Group, Inc. For: Mar 02 Filed by: Hernandez Gerardo
Medium
Report
Form 4 TransMedics Group, Inc. For: Mar 02 Filed by: Hernandez Gerardo
3/4
08:40 pm
tmdx
Form 4 TransMedics Group, Inc. For: Jan 23 Filed by: Corcoran Nicholas
Medium
Report
Form 4 TransMedics Group, Inc. For: Jan 23 Filed by: Corcoran Nicholas
3/4
08:40 pm
tmdx
Form 4 TransMedics Group, Inc. For: Mar 02 Filed by: Ranganath Anil P.
Medium
Report
Form 4 TransMedics Group, Inc. For: Mar 02 Filed by: Ranganath Anil P.
3/4
04:34 pm
tmdx
Form 144 TransMedics Group, Inc. Filed by: Hernandez Gerardo
Medium
Report
Form 144 TransMedics Group, Inc. Filed by: Hernandez Gerardo
3/4
04:23 pm
tmdx
Form 144 TransMedics Group, Inc. Filed by: Lovell Stephanie
Medium
Report
Form 144 TransMedics Group, Inc. Filed by: Lovell Stephanie
3/4
04:19 pm
tmdx
Form 144 TransMedics Group, Inc. Filed by: Weill David
Medium
Report
Form 144 TransMedics Group, Inc. Filed by: Weill David
2/27
08:25 am
tmdx
Form 8-K TransMedics Group, Inc. For: Feb 27
Medium
Report
Form 8-K TransMedics Group, Inc. For: Feb 27
2/24
04:16 pm
tmdx
Form 10-K TransMedics Group, Inc. For: Dec 31
High
Report
Form 10-K TransMedics Group, Inc. For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
25.3%
3/2 TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call Transcript [The Motley Fool] 19.5%
4/13 Form 8-K TransMedics Group, Inc. For: Apr 10 12.4%
3/17 Form 10-K TransMedics Group, Inc. For: Dec 28 12.0%
11/1 2 Hot Healthcare IPOs [The Motley Fool] 10.0%
8/22 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.6%
7/17 TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 6.9%
12/12 Form 4 TransMedics Group, Inc. For: Dec 12 Filed by: KANIA EDWIN M JR 6.7%
4/14 Form DEF 14A TransMedics Group, Inc. For: Jun 04 6.4%
4/7 TransMedics Group Inc (NASDAQ: TMDX) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $25.00 price target on the stock. 4.7%
3/2 TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call Transcript [The Motley Fool] 19.5%
4/13 Form 8-K TransMedics Group, Inc. For: Apr 10 12.4%
3/17 Form 10-K TransMedics Group, Inc. For: Dec 28 12.0%
11/1 2 Hot Healthcare IPOs [The Motley Fool] 10.0%
8/22 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.6%
7/17 TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 6.9%
12/12 Form 4 TransMedics Group, Inc. For: Dec 12 Filed by: KANIA EDWIN M JR 6.7%
4/14 Form DEF 14A TransMedics Group, Inc. For: Jun 04 6.4%
4/7 TransMedics Group Inc (NASDAQ: TMDX) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $25.00 price target on the stock. 4.7%
TOP News Decliners
3/14
TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
-18.2%
11/6 TransMedics Reports Third Quarter 2019 Financial Results -10.9%
3/6 Form 4 TransMedics Group, Inc. For: Feb 27 Filed by: DAMME LAURA -10.8%
3/27 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.8%
4/14 TransMedics Group Inc (NASDAQ: TMDX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $19.00 price target on the stock. -8.7%
8/7 TransMedics Reports Second Quarter 2019 Financial Results -6.2%
2/19 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 -4.9%
3/20 TransMedics Group Inc (NASDAQ: TMDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.8%
2/28 Form 8-K TransMedics Group, Inc. For: Feb 27 -4.7%
5/6 Form 4 TransMedics Group, Inc. For: May 06 Filed by: Lung Biotechnology PBC -4.6%
11/6 TransMedics Reports Third Quarter 2019 Financial Results -10.9%
3/6 Form 4 TransMedics Group, Inc. For: Feb 27 Filed by: DAMME LAURA -10.8%
3/27 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.8%
4/14 TransMedics Group Inc (NASDAQ: TMDX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $19.00 price target on the stock. -8.7%
8/7 TransMedics Reports Second Quarter 2019 Financial Results -6.2%
2/19 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 -4.9%
3/20 TransMedics Group Inc (NASDAQ: TMDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.8%
2/28 Form 8-K TransMedics Group, Inc. For: Feb 27 -4.7%
5/6 Form 4 TransMedics Group, Inc. For: May 06 Filed by: Lung Biotechnology PBC -4.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: